Orbital Pseudotumor as a Rare Extrahepatic Manifestation of Hepatitis C Infection

Case Reports in Gastroenterology

Volumn 10, Issue 1, 2016, Pages 108-114

  Misselwitz, Benjamin ^a   Epprecht, Jana ^a   Mertens, Joachim ^a   Biedermann, Luc ^a   Scharl, Michael ^a   Haralambieva, Eugenia ^a   Lutterotti, Andreas ^a   Weber, Konrad P ^a   Müllhaupt, Beat ^a   Chaloupka, Karla ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Extrahepatic manifestation; Hepatitis C; Idiopathic orbital inflammation; Lymphocytic dacryoadenitis; Orbital pseudotumor

Indexed keywords

C REACTIVE PROTEIN; CD20 ANTIGEN; CD5 ANTIGEN; FLUORODEOXYGLUCOSE; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PREDNISONE; PROTEIN; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; STEROID;

ADULT; AMBLYOPIA; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; B LYMPHOCYTE; CASE REPORT; CAVERNOUS SINUS; CEREBROSPINAL FLUID CYTOLOGY; CHRONIC HEPATITIS C; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DACRYOCYSTITIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; EXOPHTHALMOS; EYE BIOPSY; EYE PAIN; FOLLOW UP; GAIT DISORDER; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C VIRUS SUBTYPE 1B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; LACRIMAL GLAND; LEUKOCYTE COUNT; LIVER HILUS; LIVER PARENCHYMA; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MYOPIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; ORBIT PSEUDOTUMOR; PATHOPHYSIOLOGY; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PTOSIS; SALIVARY GLAND; SENSORY DYSFUNCTION; SPLEEN SIZE; STEROID THERAPY; SUPERIOR RECTUS MUSCLE; T LYMPHOCYTE; TINNITUS; TREATMENT RESPONSE; VESTIBULOCOCHLEAR NERVE; VESTIBULOCOCHLEAR NERVE DISEASE; VIRUS LOAD;

EID: 84973890824     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000444011     Document Type: Article

References (24)

1. Mohd Hanafiah K, et al: Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57:1333-1342.
2. Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002;36(5 suppl 1):S35-S46.
3. Wong RJ, et al: Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148:547-555.
4. Cacoub P, et al: Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis 2014;46(suppl 5):S165-S173.
5. Poynard T, et al: Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002;9:295-303.
6. Hilsabeck RC, Perry W, Hassanein TI: Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002;35:440-446.
7. AASLD/IDSA HCV Guidance Panel: Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015;62:932-954.
8. Zignego AL, et al: Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol 2015;11:15-31.
9. Ferri C, et al: Hepatitis C virus syndrome: a constellation of organ-and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer. World J Hepatol 2015;7:327-343.
10. Giordano TP, et al: Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007;297:2010-2017.
11. Gisbert JP, et al: Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003;125:1723-1732.
12. Tampaki M, Koskinas J: Extrahepatic immune related manifestations in chronic hepatitis C virus infection. World J Gastroenterol 2014;20:12372-12380.
13. Carrozzo M: Oral diseases associated with hepatitis C virus infection. Part 1. Sialadenitis and salivary glands lymphoma. Oral Dis 2008;14:123-130.
14. Negro F, et al: Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology 2015;149:1345-1360.
15. Mouelhi L, et al: Transverse myelitis associated with chronic viral hepatitis C. Tunis Med 2010;88:116-118.
16. Kawamura Y, et al: Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am J Med 2007;120:1034-1041.
17. European Association for Study of Liver: EASL Recommendations on treatment of hepatitis C 2015. J Hepatol 2015;63:199-236.
18. Cacoub P, Terrier B, Saadoun D: Hepatitis C virus-induced vasculitis: therapeutic options. Ann Rheum Dis 2014;73:24-30.
19. Ramos-Casals M, et al: Primary Sjögren syndrome: hematologic patterns of disease expression. Medicine (Baltimore) 2002;81:281-292.
20. Loustaud-Ratti V, et al: Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 2001;28:2245-2251.
21. Pawlotsky JM, et al: From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol 2015;62(1 suppl):S87-S99.
22. Morley AM, et al: Sarcoid-related dacryoadenitis following treatment with interferon alpha and ribavarin for hepatitis C. Orbit 2011;30:27-29.
23. Hwang, CJ, Gausas RE: Sarcoid-like granulomatous orbital inflammation induced by interferon-alpha treatment. Ophthal Plast Reconstr Surg 2008;24:311-313.
24. Paydas S: Hepatitis C virus and lymphoma. Crit Rev Oncol Hematol 2015;93:246-256.